S100A4 overexpression proves to be independent marker for breast cancer progression.
BACKGROUND
Breast cancer is the most common cancer and cause of deaths in women around the world. Oncogene amplification usually occurs late in tumor progression and correlates well with aggressiveness of tumor. In fact the function of the S100A4 protein and its role in metastasis is unclear at present. The purpose of the study was to determine the expression of S100A4 protein in the invasion status and metastatic potential of breast cancer by using tissue microarray and to determine its role in breast cancer based on the expression of S100A4 gene product.


METHODS
S100A4 protein expression was examined by immunohistochemistry (IHC) using commercially available tissue microarray containing malignant and normal breast tissue cores from 216 patients.


RESULTS
S100A4 was absent in normal breast tissues while positive in 45.1% of infiltrating ductal carcinoma (IDC) node negative and 48.8% of infiltrating lobular carcinoma node negative. In paired samples, S100A4 protein was expressed in 13.5% of IDC node positive cases and 35.1% of matched lymph node metastasis.


CONCLUSIONS
S100A4 protein expression appears widely expressed in early and advanced breast cancer stages compared with normal breast. Our study suggests S100A4 may play a role in breast cancer progression and may prove to be an independent marker of breast cancer which appears to be down regulated in more advanced stages of breast cancer.
Ismail
Nawfal I
NI
Advanced Medical and Dental Institute (AMDI), Universiti Sains Malaysia (USM), Penang, Malaysia. nofal_ishahad@yahoo.com
Kaur
Gurjeet
G
Hashim
Hasnah
H
Hassan
Mohammed S
MS
J Pathol. 2002 Mar;196(3):292-9
11857492
J Biol Chem. 1994 Aug 5;269(31):19679-82
8051043
Jpn J Cancer Res. 1994 Aug;85(8):831-9
7928629
Surg Oncol. 1997 Dec;6(4):209-13
9775407
J Laryngol Otol. 1998 Oct;112(10):944-7
10211217
Int J Oncol. 2001 Apr;18(4):715-20
11251165
Trends Biochem Sci. 1996 Apr;21(4):134-40
8701470
Arch Otolaryngol Head Neck Surg. 1987 Jan;113(1):78-80
3790289
Sci Am. 1996 Feb;274(2):92-7
8560215
Laryngoscope. 1987 Dec;97(12):1438-42
3316887
Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6547-51
8341667
J Biol Chem. 2002 Jul 19;277(29):26396-402
11994292
Acta Cytol. 1967 Nov-Dec;11(6):470-2
5236189
Mol Pathol. 2002 Aug;55(4):250-61
12147716
Laryngoscope. 1977 Jun;87(6):843-61
194130
Surg Gynecol Obstet. 1986 Oct;163(4):399-404
3020723
Int J Oncol. 2002 May;20(5):937-41
11956586
Cell Commun Signal. 2003 Aug 15;1(1):1
14606958
Biochim Biophys Acta. 2002 Nov 4;1600(1-2):74-83
12445462
Otolaryngol Head Neck Surg. 1999 Jun;120(6):834-40
10352436
Cancer Res. 2000 Mar 15;60(6):1595-603
10749128
Biochemistry. 1983 Mar 29;22(7):1734-40
6849880
J Natl Cancer Inst. 1996 Feb 21;88(3-4):173-82
8632491
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2309-16
9815629
Head Neck Surg. 1986 Nov-Dec;9(2):82-92
3623942
Head Neck Surg. 1980 Nov-Dec;3(2):132-41
7440180
Oncogene. 2001 Aug 2;20(34):4685-95
11498791
Head Neck Surg. 1986 Jan-Feb;8(3):177-84
3744850
Postgrad Med. 1987 Oct;82(5):105-8, 110-2
2823241
Int J Oncol. 2000 Jun;16(6):1125-31
10811984
APMIS. 2003 May;111(5):539-45
12887505
Biochemistry. 1994 May 31;33(21):6732-8
8204608
J Cell Biol. 1994 Mar;124(5):757-68
8120097
APMIS. 2000 Mar;108(3):195-200
10752688
Int J Cancer. 2000 Mar 20;89(2):198-208
10754500
Gastroenterology. 2002 Nov;123(5):1478-84
12404222
N Engl J Med. 1998 Jul 23;339(4):223-8
9673300
Cancer Res. 1991 Feb 1;51(3):1020-5
1670997
Breast Cancer Res Treat. 1993;25(2):165-74
8347848
J Biol Chem. 2000 Dec 29;275(52):41278-86
11018041
Medscape Womens Health. 2002 Jul-Aug;7(4):1
12466733
Oncogene. 1993 Apr;8(4):999-1008
8455951
J Biol Chem. 2003 Aug 8;278(32):30063-73
12756252
Arch Otolaryngol Head Neck Surg. 1991 Nov;117(11):1251-6
1747227
Acta Cytol. 1999 May-Jun;43(3):515-7
10349394